Business Standard

ED seeks NBWs against Guj firm's 4 directors in 50-bn money laundering case

The ED has registered the alleged bank fraud case against the firm SBL under sections of the Prevention of Money Laundering Act

money, mudra scheme, bribe

Press Trust of India New Delhi

The Enforcement Directorate Monday approached a Delhi court seeking issuance of open ended non-bailable warrants (NBW) against four directors of a Gujarat pharma firm in a Rs 50 billion money laundering probe case.

The agency has sought warrants against Sterling Biotech Ltd (SBL) directors Nitin Jayantilal Sandesara, Chetankumar Jayantilal Sandesara, Dipti Chetan Sandesara and Hiteshkumar Narendrabhai Patel.

Additional Sessions Judge Siddharth Sharma listed the matter for hearing on January 5.

The ED has registered the alleged bank fraud case against the firm SBL under sections of the Prevention of Money Laundering Act (PMLA).

The accused are also being probed by the ED for allegedly bribing senior income tax department officials as part of an earlier criminal complaint.

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 24 2018 | 3:20 PM IST

Explore News